ASSOCIATION BETWEEN PLASMA ADIPONECTIN LEVELS AND BIOCHEMICAL, HISTOPATHOLOGICAL PARAMETERS IN PATIENTS WITH GASTRIC CARCINOMA UNDERGOING CURATIVE SURGERY
Main Article Content
Abstract
Objectives: To investigate the relationship between preoperative plasma adiponectin (APNa) levels and biochemical characteristics, as well as histopathological features of tumors in patients with gastric carcinoma. Methods: A descriptive study was conducted on 68 patients with gastric carcinoma who underwent curative surgery at Military Hospital 103 from July 2021 to December 2023. Preoperative APN levels were quantified using the sandwich ELISA technique (FineTest). Patients were divided into two groups based on the median APNa level; data were analyzed using SPSS 26.0. Results: In the group with high plasma APNa levels, plasma albumin levels were significantly lower compared to the group with low APNa levels, with p = 0.035. Conversely, plasma CEA levels were significantly higher in the high APNa group (p = 0.003). There were no significant differences in tumor characteristics between the high and low APN groups. Conclusion: Patients with high plasma APNa levels had significantly lower albumin levels and higher CEA levels compared to those with low APNa levels (p < 0.05).
Keywords
Gastric carcinoma, Adiponectin, Biochemical indice, Tumor characteristics, Tumor marker
Article Details
References
2. Hebbard L, Ranscht B. Multifaceted roles of Adiponectin in cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 2014; 28(1):59-69.
3. Seker M, Bilici A, Sonmez B, et al. The association of serum adiponectin levels with histopathological variables in gastric cancer patients. Med Oncol. 2010; 27(4):1319-1323.
4. Choi HM, Doss HM, Kim KS. Multifaceted physiological roles of adiponectin in inflammation and diseases. International journal of molecular sciences. 2020; 21(4).
5. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020.
6. Kerem M, Ferahkose Z, Yilmaz UT, et al. Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol. 2008; 14(23):3633-3641.
7. Batista ML, Olivan M, Alcantara PSM, et al. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine. 2013; 61(2):532-539.
8. Wang Q, Yang Y, Zhang YP, et al. Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer. Med Oncol. 2014; 31(12):289.
9. Gariballa S, Alkaabi J, Yasin J, et al. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord. 2019; 19(1):55.
10. Ishikawa M, Kitayama J, Kazama S, et al. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005; 11(2 Pt 1):466-472.
 
                